Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company
focusing on creating value for people living with
neurology and immunology conditions.
Twitter Feed
-
RT @Georgia_Bio: @GeorgiaBioEd hosted a Biotech Immersion program for high school biology & biotech teachers this June. Sponsored by local…
— UCB News (@ucb_news) 22.06.2018 -
At just 21 months old, Johannesburg-born Tim Dreyer was diagnosed with sclerosteosis, an extremely rare genetic bone condition. Learn more about how his condition is furthering #osteoporosis research: https://t.co/DeX1bKdX6r https://t.co/7TGs1arEfN
— UCB News (@ucb_news) 22.06.2018 -
RT @DonBrentino: #UCB Japan is blowing out 30 candles this year and UCB Belgium even celebrates 90 years since its creation, quite an achie…
— UCB News (@ucb_news) 22.06.2018